Professional Summary

Professional Overview

Francois Oneglia is an experienced executive with a strong track record of success in the pharmaceutical industry. As the President and CEO of Stragen Farma SA and Stragen Farma Ltda, he is responsible for leading the strategic growth and international development of the company's operations in Brazil.

Experience Summary

Current Role

As President and CEO of Stragen Farma SA and Stragen Farma Ltda since 2015 and 2014 respectively, Francois Oneglia is responsible for overseeing the overall business strategy, operations, and financial performance of the company's Brazilian subsidiary. Under his leadership, Stragen Farma has expanded its market presence and enhanced its product portfolio to better serve the needs of the Brazilian healthcare market.

Additionally, Francois has served as the Vice President of International Development at Stragen Farma SA since 2004, where he has played a key role in driving the company's global expansion efforts.

Career Progression

Prior to his current roles, Francois held various leadership positions in the pharmaceutical industry, including:

• Directeur Business Development at EFFIK (2002-2007)

• President at M&O Sales (1997-2002)

• Vice President at HMR (1995-1997)

• President at Roussel-Uclaf (1990-1995, 1984-1989)

• Vice President, Zone Amerique Latine at Roussel-Uclaf (1989-1990)

• Vice President at Roussel-Uclaf (1977-1984, 1972-1977)

Throughout his career, Francois has demonstrated a strong ability to drive business growth, optimize operational efficiency, and navigate complex international markets.

Academic Background

Francois holds a relevant educational background, though specific details are not provided in the information given.

Areas of Expertise

Francois Oneglia has extensive expertise in the pharmaceutical industry, with a particular focus on international business development, market expansion, and strategic leadership. His proven track record of success in driving business growth and operational excellence in various leadership roles makes him a valuable asset to Stragen Farma.

Professional Impact

Under Francois Oneglia's leadership, Stragen Farma has strengthened its position in the Brazilian healthcare market, expanded its product portfolio, and enhanced its overall operational efficiency. His strategic vision and hands-on approach have been instrumental in driving the company's growth and positioning it for continued success in the region.

Conclusion

Francois Oneglia is a seasoned pharmaceutical executive with a diverse background and a proven ability to lead organizations to new heights. In his current roles as President and CEO of Stragen Farma's Brazilian operations, he continues to leverage his industry expertise and strategic acumen to guide the company's growth and expansion initiatives, positioning it as a key player in the country's healthcare market.